Portfolio Design Labs’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.35M Buy
4,560
+3
+0.1% +$891 0.24% 87
2025
Q4
$1.24M Buy
4,557
+62
+1% +$16.8K 0.21% 124
2025
Q3
$1.21M Sell
4,495
-8,904
-66% -$2.42M 0.21% 129
2025
Q2
$3.69M Buy
13,399
+927
+7% +$252K 0.73% 37
2025
Q1
$3.31M Sell
12,472
-1,515
-11% -$374K 0.68% 49
2024
Q4
$3.25M Buy
13,987
+4,661
+50% +$1.07M 0.67% 39
2024
Q3
$2.06M Buy
+9,326
New +$1.93M 0.57% 53
2024
Q1
Sell
-2,816
Closed -$593K 116
2023
Q4
$593K Buy
+2,816
New +$601K 0.22% 79

Other funds holding CME

Portfolio Design Labs's CME Position: Q1 2026 in Review

Portfolio Design Labs increased its CME Group (CME) stake by 0.07% in Q1 2026, buying an estimated $891 and bringing the position to 4,560 shares worth $1.35M. The position accounts for 0.24% of the portfolio, ranked #87.

Portfolio Design Labs first reported a position in CME in Q4 2023 and has held it in 8 quarters since. The position peaked at $3.69M in Q2 2025. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Portfolio Design Labs held 4,560 shares of CME Group worth $1.35M as of Q1 2026.
  • Portfolio Design Labs bought 3 CME Group shares in Q1 2026, an estimated $891.
  • CME Group made up 0.24% of Portfolio Design Labs's portfolio in Q1 2026, its #87 holding.
  • Portfolio Design Labs first reported a position in CME Group in Q4 2023 and has held it in 8 quarters since.
  • Portfolio Design Labs's CME Group position peaked at $3.69M in Q2 2025.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Portfolio Design Labs's 13F filing for Q1 2026, filed 11 May 2026.